¼¼°èÀÇ »ó¾÷¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸® ½Ã½ºÅÛ ½ÃÀå
Commercial Biotechnology Separation Systems
»óǰÄÚµå : 1513910
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 273 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,068,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,204,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

»ó¾÷¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 310¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»ó

2023³â¿¡ 253¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â »ó¾÷¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 2.9%·Î ¼ºÀåÇßÀ¸¸ç 2030³â¿¡´Â 310¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±âÁ¸ ¹æ¹ýÀº CAGR 2.7%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 190¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Çö´ëÀû ¹æ¹ý ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È CAGR 3.3%ÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 69¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ »ó¾÷¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸® ½Ã½ºÅÛ ½ÃÀåÀº 2023³â 69¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 60¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023-2030³âÀÇ CAGRÀº 4.8%ÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.6%¿Í 2.4%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è »ó¾÷¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸® ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

»ó¾÷¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸® ½Ã½ºÅÛÀº »ýüºÐÀÚ¿Í ´Ü¹éÁúÀÇ Á¤Á¦ ¹× ºÐ¼®¿¡ ÇʼöÀûÀ̸ç ÀǾàǰ, ³ó¾÷, ¿¡³ÊÁö µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °í±Þ ½Ã½ºÅÛÀº ºÐ¸® ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú ¹ÙÀÌ¿À ÀǾàǰ¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡·Î ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀåÀÇ ¼ºÀåÀº FDA¿Í °°Àº ±ÔÁ¦±â°üÀÌ Á¤ÇÏ´Â ¾ö°ÝÇÑ ÀûÀýÇÑ Á¦Á¶ ±âÁØ(GMP) °¡À̵å¶óÀÎÀ» ÁؼöÇϱâ À§ÇØ Á¤±³ÇÑ ºÐ¸® ¹æ¹ý¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖÀ½À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÃÖ±ÙÀÇ µ¿ÇâÀ¸·Î´Â Sony CorporationÀÇ SFA-Life Sciences Cloud PlatformÀ̳ª Tosoh Bioscience GmbHÀÇ Octave BIO ¸ÖƼ Ä÷³ Å©·Î¸¶Åä±×·¡ÇÇ ½Ã½ºÅÛ µîÀÇ ½Ã½ºÅÛÀÇ °³¹ßÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸®ÀÇ È¿À²¼ºÀ» ³ôÀ̰í ÁøÈ­ÇÏ´Â ¾÷°è Ç¥ÁØ¿¡ ´ëÀÀÇÏ°í ±Þ¼ºÀåÇÏ´Â »ýüºÐÀÚ¿Í ´Ü¹éÁú ½ÃÀåÀ» Áö¿øÇÕ´Ï´Ù.

¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¸® ½Ã½ºÅÛÀÇ Ã¤¿ë°ú È®´ë´Â ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ¾î ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¾ß Àüü¿¡¼­ÀÇ °ü·Ã¼º°ú À¯¿ë¼ºÀÇ Áõ´ë¸¦ È®½ÇÈ÷ Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¸¸¼ºÁúȯÀÇ ¸¸¿¬°ú ¸ÂÃãÇü ÀÇ·áÀÇ ÃßÁøÀº ¹ÙÀÌ¿ÀÀǾàǰ ¼ö¿ä¸¦ ³ôÀ̰í ÀÖÀ¸¸ç, Ä¡·á¿ë »ýüºÐÀÚÀÇ Á¤Á¦¿¡ È¿°úÀûÀÎ ºÐ¸® ½Ã½ºÅÛÀÌ ÇÊ¿äÇÕ´Ï´Ù. °­È­ Å©·Î¸¶Åä±×·¡ÇÇ, ¿©°ú, ¿ø½ÉºÐ¸® µîÀÇ ºÐ¸® ¹æ¹ýÀÇ ±â¼úÀû Áøº¸´Â º¹ÀâÇÑ »ý¹°ÇÐÀû È¥ÇÕ¹°À» º¸´Ù È¿À²ÀûÀ¸·Î Ãë±ÞÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Áؼö´Â ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö Á¦Ç°ÀÇ °í¼øµµ ¹× °íǰÁúÀ» Àǹ«È­ÇÏ¿© ÷´Ü ºÐ¸® ÇÁ·Î¼¼½ºÀÇ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ƯÈ÷ BRIC ±¹°¡ µî ½ÅÈï ½ÃÀå¿¡¼­ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¾ß¸¦ È®´ëÇÏ°í ¿¬±¸°³¹ß¿¡ ¾öû³­ ÅõÀÚ¸¦ ÇÔÀ¸·Î½á °íµµÀÇ ºÐ¸®±â¼ú¿¡ ´ëÇÑ ¿ä±¸¸¦ ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù.

»õ·Î¿î »ý¹° Á¦Á¦ÀÇ µµÀÔ°ú ±âÁ¸ÀÇ ¹ÙÀÌ¿À ÀǾàǰ¿¡¼­ ½Äǰ, À½½Ä, È­Àåǰ, ³ó¾÷ µî »ê¾÷À¸·ÎÀÇ ºÐ¸® ½Ã½ºÅÛÀÇ ÀÀ¿ë È®´ë¿Í °°Àº »õ·Î¿î µ¿Çâ°ú ÃßÁø·ÂÀº ¹ÙÀÌ¿À Å×Å©³î·ÎÁö ºÐ¸® ½Ã½ºÅÛÀÇ Àû¿ë ¹üÀ§ÀÇ È®´ë¸¦ ºÎ°¢ ÀÖ½À´Ï´Ù. Àç·á °úÇÐÀÇ ¹ßÀüÀº ºÐ¸® °øÁ¤ÀÇ ¼º´ÉÀ» Çâ»ó½ÃŰ°í ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö »ý»ê¿¡ ÇʼöÀûÀÎ ¼øµµ ¼öÁذú ¼öÀ²À» Çâ»ó½Ãŵ´Ï´Ù. IoT, AI, ¸Ó½Å·¯´×À» Æ÷ÇÔÇÑ µðÁöÅÐ ±â¼úÀ» ºÐ¸® ½Ã½ºÅÛ¿¡ ÅëÇÕÇϸé ÀÛ¾÷À» °£¼ÒÈ­Çϰí ÇÁ·Î¼¼½º¸¦ ½Ç½Ã°£ ¸ð´ÏÅ͸µÇϰí ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼¼°èÀÇ °Ç°­ À§±âµµ Ä¡·áÁ¦ ¹× ¹é½Å Á¦Á¶¿¡¼­ ºÐ¸® ½Ã½ºÅÛÀÇ Áß¿äÇÑ ¿ªÇÒ¿¡ ½ºÆ÷Æ®¶óÀÌÆ®¸¦ Àû¿ëÇÏ¿© À¯Çà¿¡ ´ëºñÇÏ°í ´ëÀÀÇÏ´Â ºÐ¸® ½Ã½ºÅÛÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù. ¸¶Áö¸·À¸·Î, ÀÚ±Ý Á¶´Þ°ú º¥Ã³ ijÇÇÅ» ÅõÀÚ Áõ°¡´Â ÷´Ü ºÐ¸® ±â¼úÀÇ µµÀÔÀ» °¡´ÉÇÏ°Ô Çϰí, Çõ½ÅÀ» ÃËÁøÇϰí, ÷´Ü ½Ã½ºÅÛÀ» ½±°Ô ¾ò°í, ½ÃÀå ¼ºÀå°ú ÁøÈ­¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñÀÇ 46»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Commercial Biotechnology Separation Systems Market to Reach US$31.0 Billion by 2030

The global market for Commercial Biotechnology Separation Systems estimated at US$25.3 Billion in the year 2023, is expected to reach US$31.0 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$19.0 Billion by the end of the analysis period. Growth in the Modern Method segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 4.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Commercial Biotechnology Separation Systems Market - Key Trends and Drivers Summarized

Commercial biotechnology separation systems are essential for the purification and analysis of biomolecules and proteins, playing a pivotal role in various sectors including pharmaceuticals, agriculture, and energy. These advanced systems have become integral due to continuous developments in separation technologies and a global increase in demand for biopharmaceutical products. The market's growth is buoyed by the rising need for sophisticated separation methods to adhere to stringent Good Manufacturing Practices (GMP) guidelines set by regulatory bodies like the FDA. Recent advancements include the development of systems such as the SFA - Life Sciences Cloud Platform by Sony Corporation and the Octave BIO multi-column chromatography system by Tosoh Bioscience GmbH. These innovations enhance the efficiency of biotechnological separations, catering to evolving industry standards, and support the burgeoning market for biomolecules and proteins.

The adoption and expansion of biotechnology separation systems are driven by several critical factors, ensuring their increasing relevance and utility across the biotechnology field. Notably, the growing prevalence of chronic diseases and the push towards personalized medicine have escalated the demand for biopharmaceuticals, necessitating effective separation systems for therapeutic biomolecule purification. Technological advancements in separation methods, such as enhanced chromatography, filtration, and centrifugation, allow for more efficient handling of complex biological mixtures. Additionally, strict regulatory compliance mandates high purity and quality in biotechnological products, bolstering the need for advanced separation processes. The expansion of the biotechnology sector, especially in emerging markets like the BRIC countries, coupled with significant investments in research and development, further stimulates the need for sophisticated separation technologies.

Emerging trends and drivers such as the introduction of new biologics and the expansion of separation system applications beyond traditional biopharmaceuticals into industries like food, beverage, cosmetics, and agriculture, highlight the broadening scope of biotechnology separation systems. Advances in material science enhance the performance of separation processes, increasing purity levels and yields crucial for biotechnological production. The integration of digital technologies, including IoT, AI, and machine learning, into separation systems streamlines operations, enabling real-time monitoring and optimization of processes. Global health crises have also spotlighted the vital role of separation systems in manufacturing therapeutics and vaccines, emphasizing their importance in pandemic preparedness and response. Lastly, increased funding and venture capital investments are enabling the adoption of cutting-edge separation technologies, fostering innovation and facilitating the acquisition of advanced systems, further driving the market's growth and evolution.

Select Competitors (Total 46 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â